The excessive release of serotonin caused by MDMA use can lead to a notable reduction of this neurotransmitter in the brain. As a consequence, people may experience negative psychological ...
Lykos Therapeutics may have shed three-quarters of its staff in the wake of the FDA's rejection of its MDMA candidate for post-traumatic stress disorder, but the biotech’s new leadership ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback